FeesSafety
Pluang+

Pilot plant begins producing NdPr oxide and metal from Halleck Creek rare earth ore in US, advancing supply chain independence.

Market News
09 Nov 2026, 15:33 WIB
GlobeNewsWire
View Source
Bullish
Pilot plant begins producing NdPr oxide and metal from Halleck Creek rare earth ore in US, advancing supply chain independence.

American Rare Earths has started operations at a small-scale pilot plant in the US to produce neodymium and praseodymium (NdPr) oxide and metal from Halleck Creek ore. This initiative aims to develop the midstream processing step from oxide to metal, a critical bottleneck currently dominated by China, supporting US supply chain independence. The program includes laboratory verification, continuous pilot production of purified NdPr oxide, and conversion to NdPr metal, with results expected by Q1 2027 to guide a larger demonstration plant. This marks a significant step toward establishing a vertically integrated rare earth supply chain within the US.

American Rare Earths' new pilot plant project offers context for basic materials investors. For readers following this sector, here is Pluang's market snapshot as of Nov 09, 2026 20:13 WIB: 68 of 83 US basic materials stocks rose today. Notable movers include ARIS at USD 16.26 (+3.90%), SBSW at USD 9.87 (+3.89%), and TGB at USD 7.22 (+3.88%).

More News

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...

Market News
Neutral
46 minutes ago
New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...

Company Fundamentals
Bullish
1 hour ago
Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...

Bearish
1 hour ago
Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...

Market News
Bullish
1 hour ago
ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App